Tifcemalimab and Toripalimab Trial in Lymphoma
In a groundbreaking advancement in oncology, a recent Phase I clinical trial has explored the therapeutic potential of tifcemalimab, both...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In a groundbreaking advancement in oncology, a recent Phase I clinical trial has explored the therapeutic potential of tifcemalimab, both...
In a groundbreaking advance for thyroid cancer research, scientists have successfully delineated two distinct molecular subtypes of thyroid carcinoma using...
In a groundbreaking study published in BioMedical Engineering OnLine, researchers have unveiled compelling evidence supporting the superiority of concurrent chemoradiotherapy...
A groundbreaking study published in BMC Cancer unveils a promising therapeutic advancement for elderly patients suffering from unresectable hepatocellular carcinoma...
In a groundbreaking advancement for the treatment of non-small cell lung cancer (NSCLC), researchers have unveiled promising results from a...
In the high-stakes arena of liver cancer surgery, the ability to predict post-operative complications is not just advantageous—it can be...
In the relentless battle against gliomas, a notoriously aggressive and often deadly form of brain cancer, the quest for effective...
In a groundbreaking study published in BMC Cancer, researchers have unveiled compelling evidence positioning E2F transcription factor 2 (E2F2) as...
In recent years, the field of oncology has witnessed a surge of interest in the intricate relationship between autophagy and...
In a groundbreaking study published in Genes and Immunity in 2025, researchers led by Xu, Guo, and Ning have delivered...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine